Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Claudin18.2 is a tight junction protein. Currently, the application of Claudin 18.2 antibody in patients has achieved a great efficacy. However, there are still few systematic studies on the expression of Claudin18.2 in gastroenteropancreatic neuroendocrine neoplasms（GEP-NENs).
Conference:
Presenting Author:
Authors: Sun Y, Jiang K, Hu Y, Li J, Lu M,
Keywords: gastroenteropancreatic neuroendocrine neoplasm, claudin18.2, expression,
Introduction: Claudin 18 isoform 2 (CLDN18.2) is selectively expressed in normal and neoplastic gastric tissue and some pancreatic neoplasia. Anti-CLDN18.2 is an investigational therapy in gastric and pancreatic adenocarcinoma and a sensitive and specific immunohistochemical marker in these cancers.
Conference:
Presenting Author: Smith B
Authors: Smith B, Rice K, Setthavongsack N, Woltjer R, Wong M,
Keywords: neuroendocrine, immunohistochemistry, claudin 18, CLDN18, gastric,
#3514 DLL3 expression and clinico-pathological data in 247 patients with NEN
Introduction: Delta-like protein 3 (DLL3) is currently under clinical investigation as a potential therapeutic target in small cell neuroendocrine lung cancer. Characterization of the levels and patterns of DLL3 expression in other neuroendocrine neoplasms (NEN) is limited.
Conference:
Presenting Author: Clausen M
Authors: Clausen M, Federspiel B, Carstensen F, Suppli M, Kjaer A,
Keywords: DLL3, high-grade NEN,
Introduction: Somatostatin receptor subtype 2 (SST2) immunostaining (IHC) is routinely performed in neuroendocrine tumors (NET) and recommended in acromegaly guidelines. No univocal score of SST2 IHC has been validated yet.
Conference:
Presenting Author: Campana C
Authors: Campana C, van Koetsveld P, Iyer A, van Velthuysen M, van den Dungen E,
Keywords: SST2, digital image analysis, panNET, staining intensity, percentage of positive cell,
#1545 In Vivo Expression of Survivin and XIAP in Medullary Thyroid Carcimoma
Introduction: Medullary thyroid carcinoma (MTC) accounts for approximately 5 % of all thyroid malignancies. Although surgery remains the first line therapy with curative intention, for advanced MTC current chemotherapeutic regimes do not provide promising results. Consequently, the identification of biologically relevant biomarkers that are associated with MTC progression may provide novel therapeutic targets.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Werner T